Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho
Authors
Keywords
Antiretroviral therapy, HIV, Medical risk factors, Viremia, Cholesterol, Randomized controlled trials, Hemoglobin, Viral load
Journal
PLOS MEDICINE
Volume 17, Issue 9, Pages e1003325
Publisher
Public Library of Science (PLoS)
Online
2020-09-17
DOI
10.1371/journal.pmed.1003325
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study
- (2020) Lucas E. Hermans et al. PLOS MEDICINE
- Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial
- (2019) Michael Aboud et al. LANCET INFECTIOUS DISEASES
- Persistent Low-Level Viremia while on Antiretroviral Therapy is an Independent Risk Factor for Virologic Failure
- (2019) Christie Joya et al. CLINICAL INFECTIOUS DISEASES
- Field suitability and diagnostic accuracy of the Biocentric® open real-time PCR platform for dried blood spot (DBS)-based HIV viral load quantification in Eswatini
- (2019) Bernhard Kerschberger et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
- (2019) Alison J Rodger et al. LANCET
- Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy
- (2019) Julia Fleming et al. AIDS
- How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis
- (2019) Lucia Taramasso et al. JOURNAL OF CLINICAL VIROLOGY
- SESOTHO trial (“Switch Either near Suppression Or THOusand”) – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa
- (2018) Alain Amstutz et al. BMC INFECTIOUS DISEASES
- Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment
- (2018) Enrique Bernal et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Stepping up HIV-1 low-level viraemia surveillance in South Africa
- (2018) Antonella Castagna et al. LANCET INFECTIOUS DISEASES
- Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
- (2018) Lucas E Hermans et al. LANCET INFECTIOUS DISEASES
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2018) Michael S. Saag et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Persistent low level viremia predicts subsequent virologic failure. Is it time to change the 3rd 90?
- (2018) Allahna Esber et al. CLINICAL INFECTIOUS DISEASES
- Successes and challenges in optimizing the viral load cascade to improve antiretroviral therapy adherence and rationalize second-line switches in Swaziland
- (2018) David Etoori et al. Journal of the International AIDS Society
- Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial
- (2017) Nicholas I Paton et al. Lancet HIV
- Should viral load thresholds be lowered?
- (2016) Niklaus D. Labhardt et al. MEDICINE
- Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality
- (2015) Tracy R. Glass et al. AIDS
- HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure
- (2014) Luke C. Swenson et al. AIDS
- Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study
- (2014) Noémie Boillat-Blanco et al. ANTIVIRAL THERAPY
- Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
- (2014) Nicholas I. Paton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic Review of the Use of Dried Blood Spots for Monitoring HIV Viral Load and for Early Infant Diagnosis
- (2014) Pieter W. Smit et al. PLoS One
- Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
- (2014) Chien-Yu Cheng et al. Journal of the International AIDS Society
- Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation
- (2013) C. Laprise et al. CLINICAL INFECTIOUS DISEASES
- Antiretroviral Drug Resistance in HIV-1–Infected Patients Experiencing Persistent Low-Level Viremia During First-Line Therapy
- (2011) Babafemi Taiwo et al. JOURNAL OF INFECTIOUS DISEASES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started